Recommended Topic Related To:

Kepivance

"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.

Dotarem is a gadolinium-based"...

Kepivance

PATIENT INFORMATION

Advise patients to report the following to healthcare providers:

Inform patients

  • That the safety and efficacy of Kepivance have not been established in patients with non-hematologic malignancies [see INDICATIONS AND USAGE and WARNINGS AND PRECAUTIONS]
  • Of the evidence of tumor growth and stimulation in cell culture and in animal models of non-hematopoietic human tumors [see WARNINGS AND PRECAUTIONS and CLINICAL PHARMACOLOGY]

Last reviewed on RxList: 6/14/2013
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.